We describe an extended pedigree in which second cousins are affected with cystic fibrosis (CF). Since the degree of relationship of the affected subjects is 1/32, common descent of one CF mutation was expected when the DNA laboratory undertook mutation analysis. Mutation testing showed that each CF mutation was introduced into the family by random mating and not by descent through a common ancestor. Implications for pedigree analysis and DNA testing are discussed. (JMed Genet 1995;32:401-402) The first family members tested, IV 1 and IV-2, are both homozygous for AF508. The mother (III-2) is a AF508 carrier, and the father (III 1) was not available for testing. III7 and III8, the parents of the affected cousin, were tested next. (The affected cousin, IV 3, was not referred for DNA testing). Since III-7 is the first cousin of III2, both were expected to carry the same mutation (AF508). Instead, III-7 was found to carry the G55 1D mutation,
This family illustrates an unlikely pathway of CF inheritance. The probability of III-2 and III-7 both being carriers as a result of descent of a CF mutation from a common ancestor is 1/8 (degree of relationship of first cousins). Given that their CF mutations were not inherited by common descent, the probability of both being carriers can be calculated as follows: 1/25 x 1/2 x 1/25 x 1/2 = 1/2500, where 1/25 is the probability of each father mating with a CF carrier and 1/2 is the probability of a CF mutation being passed from a carrier to her offspring. Thus, the probability of first cousins being CF carriers is 312 times less likely to arise through random matings than through common descent. In this family, assumptions based on the more likely segregation pattern could have led to inaccurate assessment of carrier status in at risk people.
It is generally agreed that people with a family history ofcystic fibrosis should be offered carrier testing.4 However, there is no consensus CF mutation panel to be used in all carrier screening.5 Given the relative frequency of CF mutations in the general population, family members at risk of being carriers of a particular CF mutation need to be counselled regarding the risk that other mutations may be segregating within the family. This family study illustrates the importance of careful pedigree analysis and comprehensive mutation testing. 
